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Genome-wide scanning versus candidate gene approach in the genetic architecture 
of common diseases 
In the Nature 7 June issue, researchers from the Welcome Trust Case Control Consortium 
(WTCCC) reported the findings of a large genome-wide association (GWA) study of 
14,000 cases of common diseases and 3000 controls studies revealing the role of several 
loci in the genetic risk of common diseases 1. 
Interestingly, almost simultaneously, researchers from the Diabetes Genetics Initiative 
(DGI) 2, the Finland–United States Investigation of NIDDM Genetics (FUSION) 3 and the 
Welcome Trust Case Control Consortium (WTCCC) 4 showed the results of other 3 large 
GWA studies in type 2 diabetes (T2D). 
We wish to make a reflection about what we have learned from these new discoveries 
that could open powerful hints in the understanding of the pathophysiology of the 
diseases, particularly T2D, as pooling all the studies, there were 16,586 patients and 
20,968 healthy controls, including the replication sets.
First, by pooling the results of all studies, the authors either confirmed or identified and 
confirmed the association of SNPs at three previously unknown loci such as CDKN2B, 
CDKAL1 of IGF2BP2 with the risk of T2D. Besides, the 3 consortia also made the effort 
of evaluating the contribution of variants in loci previously published as associated with 
the disease. For instance, the SNP rs13266634, a nonsynonymous variant in zinc 
transporter SLC30A8 and the rs1801282, a nonsynonymous variant in the PPARG gene, 
were significantly associated when pooling all the data in spite of the fact that, in single 
genome scan (DGI), neither gene showed a positive signal for the aforementioned 
variants (p value: 0.92 and 0.83 respectively). Interestingly, the studies prove the worth 
of candidate gene studies as, for instance, the association results for the common PPARG 
Pro12Ala polymorphism were expressly investigated in the light of the preceding reports 
showing the association between the variant and enhanced insulin sensitivity and 
protection against T2D 5. Thus, we wonder whether this SNP would have been carefully 
looked at even had no prior reports existed, as the data presentation reinforcing the 
previous published loci seems to be not unbiased regarding both the presumed 
information on protein function of the causal variant and the biological driven 
assumption. At that point, the whole efficiency of the genome-scans seems to be strongly 
shared between the exploratory- approach and the hypothesis-driven research. 
Finally, we wish to emphasize that by making public the access to databases, consortia 
allow other investigators to search for association between candidate genes and T2D-
related phenotypes. As an example we found, in a pilot study enrolling 1100 individuals 
that SNPs in the CLOCK (i.e. rs1554483 and rs6843722) were associated with 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
07
.1
43
8.
1 
: P
os
te
d 
18
 D
ec
 2
00
7
hypertension (p value < 0.01, and 0.01, respectively). Interestingly, the same association 
was found by the WTCCC study (rs1554483, rs4580704, rs6843722 and rs4864548 with 
p<0.039, 0.014, 0.049 and 0.019). However, these findings were not mentioned by the 
authors because of the stringent p value criteria logically used by them in the face of a 
WGA.
Then WGA may prove to be more cost effective if databases are used for seeds of 
hypothesis-driven candidate gene approaches with p value cut-off higher than the 
stringent values imposed by genome correction, even at the expense of finding false 
positive associations. We found difficult to match data from different consortia since the 
format of the datasets are not homogenous and only WTCCC gives the complete 
information for all the diseases
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